The Intellis Implantable Neurostimulation system, made by Medtronic, received FDA approval in September 2017. It is the world’s smallest fully implantable spinal cord neurostimulator for the treatment of chronic pain. By delivering high- and low-dose therapy and its ability to track patient activity to help target pain the device can potentially have an impact on the opioid epidemic. The system connects wirelessly to the Samsung Galaxy S2 Tablet, which can be used to adjust settings, set parameters, and upgrade the system. Moreover, it is safe to wear inside MRIs, provided certain precautions are taken. http://www.medtronic.com/us-en/healthcare-professionals/products/neurological/spinal-cord-stimulation-systems/intellis-platform.html.